Ribometrix scores $30 mln Series A

Durham, North Carolina-based Ribometrix, a biotechnology company, has closed $30 million in Series A financing. M Ventures led the round with participation from Amgen Ventures, Pappas Capital and Illumina Ventures. Founding investors SV Health Investors, AbbVie Ventures, Hatteras Venture Partners, MP Healthcare Venture Management, the Dementia Discovery Fund and Alexandria Venture Investments.

ManagersNorth AmericaUSHealthcareBriefs